Highlights from Day 1 of the Conference on Retroviruses and Opportunistic Infections (CROI)

Tremendous Progress Made in HIV, but Serious  Disparities Remain

February 23, 2016 :: White House Blog

Data released at this year’s CROI meeting demonstrates need for continued focus and action. This week, I’m in Boston for the annual Conference on Retroviruses and Opportunistic Infections (CROI). It’s one of the premier scientific meetings where we hear the latest research in HIV prevention and treatment. [READ MORE]

NIH-Funded Study Finds Effect of PrEP on Bone  Density is Reversible

February 23, 2016 :: NIH Newsroom

The slight loss in bone mineral density associated with HIV pre-exposure prophylaxis (PrEP) antiretroviral use is reversible in young adult patients who stop taking the drugs, according to findings presented by researchers today at the 23rd Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. [READ MORE]

NIH’s Dr. Carl Dieffenbach Shares Highlights from  Start of CROI 2016 (Video)

February 24, 2016 :: AIDS.gov Blog

After the first full day of sessions at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston yesterday, February 23, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of the day. [READ MORE]